Seven Fleet Capital Management’s Damora Therapeutics DMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.14M Buy
288,439
+4,009
+1% +$113K 1.2% 16
2026
Q2
$7.4M Buy
284,430
+183,182
+181% +$4.44M 1.22% 19
2026
Q1
$2.62M Buy
+101,248
New +$2.6M 0.82% 32

Other funds holding DMRA

Seven Fleet Capital Management's DMRA Position: Q3 2026 in Review

Seven Fleet Capital Management increased its Damora Therapeutics (DMRA) stake by 1.4% in Q3 2026, buying an estimated $113K and bringing the position to 288,439 shares worth $6.14M. The position accounts for 1.2% of the portfolio, ranked #16.

Seven Fleet Capital Management first reported a position in DMRA in Q1 2026 and has held it in 3 quarters since. The position peaked at $7.4M in Q2 2026. 115 funds tracked by Wall St. Rank hold DMRA as of Q3 2026.

  • Seven Fleet Capital Management held 288,439 shares of Damora Therapeutics worth $6.14M as of Q3 2026.
  • Seven Fleet Capital Management bought 4,009 Damora Therapeutics shares in Q3 2026, an estimated $113K.
  • Damora Therapeutics made up 1.2% of Seven Fleet Capital Management's portfolio in Q3 2026, its #16 holding.
  • Seven Fleet Capital Management first reported a position in Damora Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Seven Fleet Capital Management's Damora Therapeutics position peaked at $7.4M in Q2 2026.
  • 115 funds tracked by Wall St. Rank held Damora Therapeutics as of Q3 2026.

Based on Seven Fleet Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.